An imaging comparison of ⁶⁴Cu-ATSM and ⁶⁰Cu-ATSM in cancer of the uterine cervix

Keyphrases

• In Cancer 100%
• Cervical Cancer 100%
• 64Cu-ATSM 100%
• Imaging Comparison 100%
• Diacetyl 50%
• Tumor Uptake 50%
• Copper(II) 50%
• Image Quality 33%
• Human Cancer 33%
• Tumor 16%
• Clinical Application 16%
• Preclinical Data 16%
• Radiopharmaceuticals 16%
• Clinical Utility 16%
• Imaging Studies 16%
• In Vivo Assay 16%
• Toxicity Study 16%
• Cervical Carcinoma 16%
• Tumor Hypoxia 16%
• Clinical Pharmacology 16%
• Pharmacology 16%
• Clinical Toxicology 16%
• Patient Study 16%
• Clinical Test 16%
• Toxicology 16%
• Test-retest 16%
• Female Cancer 16%
• Low Noise 16%
• Targeted Radiopharmaceuticals 16%
• High Quality Images 16%
• Long Half-life 16%
• Investigational New Drug Application 16%
• Safety Margin 16%
• Hypoxia Targeting 16%
• Copper Radionuclides 16%
• Crossover Comparison 16%
• Muscle Activity Ratio 16%
• PET Image Quality 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Copper 64 100%
• Neoplasm 83%
• Diacetyl 50%
• Cuprous Ion 50%
• Polyethylene Terephthalate 50%
• Hypoxia 33%
• Tracer 33%
• Radiopharmaceutical Agent 33%
• Leporidae 16%
• Uterine Cervix Carcinoma 16%
• Radioisotope 16%
• Preclinical Toxicology 16%
• Preclinical Pharmacology 16%
• Toxicology 16%